SCHEMBL19079688

SCHEMBL19079688

O=C(CSc1nc2sc(-c3ccc4ncccc4c3)cc2c(=O)n1C1CC1)c1ccccc1

nearest known ligand 0.58

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PDE4D Q08499 2/20 0.58
▸ KDM4E B2RXH2 5/20 0.45
▸ CYP2C9 P11712 2/20 0.45
▸ CYP2C19 P33261 2/20 0.45
▸ HPGD P15428 2/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ SMN1; SMN2 Q16637 2/20 0.42
▸ GAA P10253 1/20 0.42
▸ POLB P06746 3/20 0.42
▸ ALDH1A1 P00352 8/20 0.41
▸ NPSR1 Q6W5P4 4/20 0.41
▸ MAPT P10636 4/20 0.41
▸ HSD17B10 Q99714 1/20 0.40
▸ L3MBTL1 Q9Y468 2/20 0.39
▸ TGM2 P21980 1/20 0.39
▸ LMNA P02545 4/20 0.38
▸ TSHR P16473 4/20 0.38
▸ TP53 P04637 1/20 0.38
▸ CHEK1 O14757 1/20 0.38
▸ BAP1 Q92560 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19079773 0.87 KDM4E (0.43) PDE4DKDM4ECYP2C9CYP2C19HPGD
SCHEMBL19079771 0.85 PDE4D (0.64) PDE4DKDM4ECYP2C9CYP2C19HPGD
SCHEMBL21133089 0.85 PDE4D (0.64) PDE4DKDM4ECYP2C9CYP2C19HPGD
SCHEMBL19079703 0.85 PDE4D (0.64) PDE4DKDM4ECYP2C9CYP2C19HPGD
SCHEMBL19090388 0.83 PDE4D (0.61) PDE4DKDM4ECYP2C9CYP2C19HPGD
SCHEMBL19079732 0.77 PDE4D (0.66) PDE4DKDM4ECYP2C9CYP2C19SMN1; SMN2
SCHEMBL19079707 0.74 PDE4D (0.74) PDE4DKDM4ECYP2C9CYP2C19CYP1A2
SCHEMBL19079691 0.74 PDE4D (1.00) PDE4DKDM4ECYP2C9CYP2C19SMN1; SMN2
SCHEMBL19079860 0.72 PDE4D (0.67) PDE4DKDM4ECYP2C9CYP2C19SMN1; SMN2
SCHEMBL19079677 0.70 PDE4D (0.64) PDE4DKDM4ECYP2C9CYP2C19HPGD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-10329304-B2 Compounds and methods for inhibition of hedgehog signaling and phosphodiesterase VANDERBILT UNIVERSITY (US) 2019-06-25 — — US disclosed
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase VANDERBILT UNIVERSITY 2017-07-06 — — US disclosed
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase VANDERBILT UNIVERSITY 2017-07-06 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-10329304-B2 Compounds and methods for inhibition of hedgehog signaling and phosphodiesterase PDE4A, PDE4B, PDE7A PDE4D 6/4885KDM4E 939/4885CYP2C9 4198/4885
US-20170190717-A1 Compounds and Methods for Inhibition of Hedgehog Signaling and Phosphodiesterase PDE4A, PDE4B, PDE7A PDE4D 6/4885KDM4E 939/4885CYP2C9 4198/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback